β2-glycoprotein 1-dependent anticardiolipin antibodies and risk of ischemic stroke and myocardial infarction: The Honolulu Heart Program

Stroke

Volumn 32, Issue 8, 2001, Pages 1701-1706

  Brey, Robin L ^a   Abbott, Robert D ^b,c,d   Curb, J David ^c,d   Sharp, Dan S ^f   Ross, G Webster ^c,d,e   Stallworth, Christian L ^a   Kittner, Steven J ^g,h  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c UNIVERSITY OF HAWAII   (United States)

^d KUAKINI MEDICAL CENTER   (United States)

^e DEPARTMENT OF VETERANS AFFAIRS   (United States)

^f NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^g UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^h BALTIMORE VA MEDICAL CENTER   (United States)

Author keywords

Antibodies; Anticardiolipin; Case control studies; Cerebrovascular disorders; Myocardial infarction; Prospective studies; Risk factors

Indexed keywords

AUTOANTIBODY; BETA2 GLYCOPROTEIN 1; CARDIOLIPIN ANTIBODY;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; STROKE;

EID: 0034884321     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.32.8.1701     Document Type: Article

References (40)

1. Antiphospholipid antibodies in cerebral ischemia in young people
2. High prevalence of antiphospholipid antibodies in children with idiopathic cerebral ischemia
3. Anticardiolipin antibody associated ischemic strokes in elderly patients without system lupus erythematosus
4. Anticardiolipin antibodies are an independent risk factor for first ischemic stroke: The Antiphospholipid Antibodies in Stroke Study (APASS) group
5. Anticardiolipin antibodies: A study of frequency in TIA and stroke
6. Prospective study of anticardiolipin antibodies in stroke
7. Lupus anticoagulant and anticardiolipin antibodies in young adults with cerebral ischemia
8. Anticardiolipin antibodies in ischemic stroke in the young: Indian experience
9. Importance of serum anticardiolipin antibody levels in coronary heart disease
10. Anticardiolipin antibodies in ischaemic heart disease: Marker or myth?
11. Anticardiolipin antibodies in an unselected stroke population
12. The frequency of phospholipid antibodies in an unselected stroke population
13. Anti-cardiolipin antibodies and risk of myocardial infarction in a prospective cohort of middle-aged men
14. Antibodies against cardiolipin and oxidatively modified LDL in 50-year-old men predict myocardial infarction
15. Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis
16. Antiphospholipid antibodies after myocardial infarction and their relation to mortality, reinfarction, and non-haemorrhagic stroke
17. Anticardiolipin antibodies are not an independent risk factor for stroke: An incident case-referent study nested within the MONICA and Vasterbotten cohort project
18. Immunology and clinical importance of antiphospholipid antibodies
19. Anticardiolipin cofactors and the differential diagnosis of autoimmune disease
20. Anticardiolipin antibodies (ACA) are directed not against cardiolipin but to a plasma cofactor
21. Risk of arterial thrombosis in patients with anticardiolipin antibodies and lupus anticoagulant
22. Association of anti-β2 glycoprotein I antibodies with lupus type circulating anticoagulants and thrombosis in systemic lupus erythematosus
23. Factors related to stroke incidence in Hawaii Japanese men: The Honolulu Heart Study
24. Elevated cholesterol is a risk factor for both coronary heart disease and thromboembolic stroke in Hawaiian Japanese men: Implications of shared risk
25. Ten year incidence of coronary heart disease in the Honolulu Heart Program: Relationship to biologic and lifestyle characteristics
26. Physical activity and coronary heart disease in meddle-aged and elderly men: The Honolulu Heart Program
27. Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii, and California: Demographic, physical, dietary and biochemical characteristics
28. Analysis of covariance and standardization as instances of prediction
29. Comparison of the effects of anticardiolipin antibodies from patients with the antiphospholipid antibody syndrome and with syphilis on platelet activation and aggregation
30. Immunohematologic characteristics of infection-associated cerebral infarction
31. Recent bacterial and viral infection is a risk factor for cerebrovascular ischemia: Clinical and biochemical studies
32. Origin of antiphospholipid antibodies: Induction of aPL by viral peptides
33. The environment and disease: Association or causation?
34. Effects of repeated freeze-thaw cycles on anticardiolipin antibody immunoreactivity
35. Differences in kaolin clotting times and platelet counts resulting from variations in specimen processing
36. Elevated anticardiolipin antibody titer is a stroke risk factor in a multiethnic population independent of isotype or degree of positivity
37. Model for the neuromuscular complications of systemic lupus erythematosus
38. Antiphospholipid syndrome: From patient's bedside to experimental animal models and back to the patient's bedside
39. Antiphospholipid antibodies in an in vivo thrombosis model in mice